| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococcus aureus (clinical isolate + methicillin-susceptible) |
≤0.06 |
≤0.06 |
≤0.06 － 32 |
Rifampicin (Rifampin) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-susceptible) |
0.25 |
0.5 |
≤0.06 － 4 |
Quinupristin/Dalfopristin (Synercid) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-susceptible) |
0.5 |
1 |
≤0.06 － 32 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-susceptible) |
0.5 |
1 |
0.12 － 4 |
Teicoplanin (Targocid) |
477 |
| Staphylococcus aureus (clinical isolate + methicillin-susceptible) |
1 |
2 |
≤0.06 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
477 |